Congratulations to Anna Popova, Haijun Cui and Sun Xueyuan, whose paper has been just accepted for publication in Advanced Healthcare Materials: "Repurposing FDA-Approved Drugs for Temozolomide-resistant IDH1 Mutant Glioma using High-Throughput Miniaturized Screening on Droplet Microarray Chip"!🥳🥳🥳
In this paper, several thousands of FDA approved drugs were screened with Glioma spheroids. This was a very successful collaboration with the group of Sevin Turcan from Heidelberg/DKFZ. The screen identified several novel compounds potent against glioma (brain tumor).